Article(id=1329905941912334421, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905930747098051, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2025.10.002, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1753027200000, receivedDateStr=2025-07-21, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795003885009, onlineDateStr=2026-11-18, pubDate=1760025600000, pubDateStr=2025-10-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795003885009, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795003885009, creator=13701087609, updateTime=1795003885009, updator=13701087609, issue=Issue{id=1329905930747098051, tenantId=1146029695717560320, journalId=1319690259887390882, year='2025', volume='56', issue='10', pageStart='1243', pageEnd='1370', issueExtLink='null', onlineDate='null', pubDate='1760025600000', pubDateStr='2025-10-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=0, createTime=1795003882347, creator='13701087609', updateTime=1795004334384, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329907827268760040, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905930747098051, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329907827268760041, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905930747098051, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1252, endPage=1260, ext={EN=ArticleExt(id=1329905942138826838, articleId=1329905941912334421, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Research Progress of Co-delivery Systems Containing Paclitaxel and Traditional Chinese Medicine Components for Antitumor Applications, columnId=1325194059773522066, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Perspectives & Review, runingTitle=null, highlight=null, articleAbstract=

Various nature products have been verified to enhance the antitumor efficacy of paclitaxel and mitigate its toxic and adverse reactions. However, the co-delivery of paclitaxel and natural products remains a significant challenge in the pharmaceutical field. In recent years, strategies such as drug self-assembly, drug carriers, and new formulation forms have been employed to concurrently deliver natural products and paclitaxel to tumor sites, aiming to exert their synergistic effects, thereby elevating antitumor activity of paclitaxel and circumventing drug resistance. This article systematically reviews relevant literature, focusing on the design strategies, release characteristics, and therapeutic effects of co-delivery systems, with the aim of providing insights and references for antitumor research combining paclitaxel and natural products.

, authors=Yihong ZHANG, Yan XIE*, authorsList=Yihong ZHANG, Yan XIE, authorCompany=null, correspAuthors=Yan XIE, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329905942440816727, articleId=1329905941912334421, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=紫杉醇与天然产物共递送系统抗肿瘤应用的研究进展, columnId=1322624444544176331, journalTitle=中国医药工业杂志, columnName=专论与综述, runingTitle=null, highlight=null, articleAbstract=

许多天然产物被证实能增强紫杉醇的抗肿瘤活性并降低其不良反应。然而,紫杉醇与天然产物的共递送仍是药剂学领域的重大挑战。近年来,通过药物自组装、药物载体、新型制剂形式等策略,已实现将天然产物与紫杉醇同时递送至肿瘤部位。这些策略能实现天然产物和紫杉醇协同作用,从而提高紫杉醇的抗肿瘤活性并克服耐药性。文章对相关文献进行了系统梳理,重点围绕共递送系统的设计思路、释药特征、作用效果阐述该领域的研究进展,以期为共递送紫杉醇与天然产物的抗肿瘤治疗提供研究思路与参考。

, authors=张义宏, 谢燕*, authorsList=张义宏, 谢燕, authorCompany=null, correspAuthors=谢燕, authorNote=

张义宏,硕士研究生,专业方向:中药制剂新技术的研究与应用。

, correspAuthorsNote=
谢燕,研究员,博士生导师,从事中药制剂新技术的研究与应用。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=3omoUFUOoY4tMnaCaB8n+g==, magXml=xR0f3Wdw6i8UdbnX13G/Hw==, pdfUrl=null, pdf=PRs5Mi2Yzk2CnG2KEgMDxw==, pdfFileSize=1449510, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=T3oyAg5My8uasOuV3yBAIg==, mapNumber=null, fund=null)}, authors=[Author(id=1329905942726029404, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905942847664222, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, authorId=1329905942726029404, language=EN, stringName=Yihong ZHANG, firstName=Yihong, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=School of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905942918967391, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, authorId=1329905942726029404, language=CN, stringName=张义宏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海中医药大学公共健康学院,上海 201203, bio={"content":"

张义宏,硕士研究生,专业方向:中药制剂新技术的研究与应用。

"}, bioImg=null, bioContent=

张义宏,硕士研究生,专业方向:中药制剂新技术的研究与应用。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905942654726232, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, xref=null, ext=[AuthorCompanyExt(id=1329905942663114841, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, companyId=1329905942654726232, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai 201203), AuthorCompanyExt(id=1329905942675697754, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, companyId=1329905942654726232, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海中医药大学公共健康学院,上海 201203)])]), Author(id=1329905942986076257, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329905943082545251, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, authorId=1329905942986076257, language=EN, stringName=Yan XIE, firstName=Yan, middleName=null, lastName=XIE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=School of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905943149654116, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, authorId=1329905942986076257, language=CN, stringName=谢燕, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=上海中医药大学公共健康学院,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905942654726232, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, xref=null, ext=[AuthorCompanyExt(id=1329905942663114841, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, companyId=1329905942654726232, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai 201203), AuthorCompanyExt(id=1329905942675697754, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, companyId=1329905942654726232, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海中医药大学公共健康学院,上海 201203)])])], keywords=[Keyword(id=1329905943254511717, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, language=EN, orderNo=1, keyword=paclitaxel), Keyword(id=1329905943317426278, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, language=EN, orderNo=2, keyword=natural product), Keyword(id=1329905943380340839, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, language=EN, orderNo=3, keyword=self-assembly), Keyword(id=1329905943443255400, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, language=EN, orderNo=4, keyword=nanocarrier), Keyword(id=1329905943497781353, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, language=EN, orderNo=5, keyword=biomimetic nanocarrier), Keyword(id=1329905943577473130, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, language=EN, orderNo=6, keyword=research progress), Keyword(id=1329905943640387691, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, language=CN, orderNo=1, keyword=紫杉醇), Keyword(id=1329905943699107948, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, language=CN, orderNo=2, keyword=天然产物), Keyword(id=1329905943762022509, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, language=CN, orderNo=3, keyword=自组装), Keyword(id=1329905943841714286, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, language=CN, orderNo=4, keyword=纳米载体), Keyword(id=1329905943904628847, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, language=CN, orderNo=5, keyword=仿生纳米载体), Keyword(id=1329905943971737712, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, language=CN, orderNo=6, keyword=研究进展)], refs=[Reference(id=1329905944198230130, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=GALLEGO-JARA J, LOZANO-TEROL G, SOLA-MARTÍNEZ R A, et al.A compressive review about taxol®: history and future challenges [J].Molecules, 2020, 25(24): 5986., articleTitle=null, refAbstract=null), Reference(id=1329905944315670643, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG S N, YE T Q, LIU Y B, et al.Research advances in clinical applications, anticancer mechanism, total chemical synthesis, semi-synthesis and biosynthesis of paclitaxel [J].Molecules, 2023, 28(22): 7517., articleTitle=null, refAbstract=null), Reference(id=1329905944386973812, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=石英香, 王 婧, 石玉荣, 等.乳腺癌紫杉醇耐药机制的研究进展[J].齐齐哈尔医学院学报, 2022, 43(6): 557-561., articleTitle=null, refAbstract=null), Reference(id=1329905944462471285, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=陆 璐, 郭青龙, 赵 丽.Src激酶家族与紫杉醇耐药相关性的研究进展[J].中国药科大学学报, 2017, 48(4): 377-383., articleTitle=null, refAbstract=null), Reference(id=1329905944521191542, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=NAGANUMA M, TAHARA K, HASEGAWA S, et al.Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the food and drug administration adverse event reporting system [J].SAGE Open Med, 2019, 7: 2050312119836011., articleTitle=null, refAbstract=null), Reference(id=1329905944592494711, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=孔欠文, 陈君君, 胡玉洁, 等.中药单体逆转紫杉醇耐药作用机制的研究进展[J].中国实验方剂学杂志, 2022,28(17): 209-216., articleTitle=null, refAbstract=null), Reference(id=1329905944676380792, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=戴 曦, 唐大春, 袁 竞, 等.和厚朴酚逆转非小细胞肺癌紫杉醇耐药的作用及机制[J].西南医科大学学报, 2024,47(4): 316-320., articleTitle=null, refAbstract=null), Reference(id=1329905944743489657, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=KARAOSMANOGLU S, ZHANG Y, ZHOU W, et al.Synthesis of carrier-free paclitaxel-curcumin nanoparticles: the role of curcuminoids [J].Bioengineering (Basel), 2022,9(12): 815., articleTitle=null, refAbstract=null), Reference(id=1329905944806404218, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=CAI Y, XU Z M, SHUAI Q, et al.Tumor-targeting peptide functionalized PEG-PLA micelles for efficient drug delivery[J].Biomater Sci, 2020, 8(8): 2274-2282., articleTitle=null, refAbstract=null), Reference(id=1329905944881901691, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=CHAN H W, ZHANG X, CHOW S, et al.Inhalable paclitaxel nanoagglomerate dry powders for lung cancer chemotherapy: design of experiments-guided development, characterization and in vitro evaluation [J].Int J Pharm, 2024, 653: 123877., articleTitle=null, refAbstract=null), Reference(id=1329905944965787772, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=KONG Y F, PAN T S, LIU B, et al.Double-layer microneedle patch loaded with HA-PBA-QCT for management of paclitaxel-induced peripheral neuropathic pain [J].Small,2025, 21(8): e2409748., articleTitle=null, refAbstract=null), Reference(id=1329905945028702333, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=QIAO L, YANG H S, GAO S J, et al.Research progress on self-assembled nanodrug delivery systems [J].J Mater Chem B, 2022, 10(12): 1908-1922., articleTitle=null, refAbstract=null), Reference(id=1329905945104199806, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=CHOWDHURY P, NAGESH P K B, HATAMI E, et al.Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells [J].J Colloid Interface Sci, 2019, 535: 133-148., articleTitle=null, refAbstract=null), Reference(id=1329905945192280191, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=程建军, 杨 鑫.三萜天然小分子自组装机制及其协同抗癌应用研究[J].药学学报, 2021, 56(8): 2102-2111., articleTitle=null, refAbstract=null), Reference(id=1329905945263583360, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=BAO Y M, ZHANG S Q, CHEN Z M, et al.Synergistic chemotherapy for breast cancer and breast cancer brain metastases via paclitaxel-loaded oleanolic acid nanoparticles[J].Mol Pharm, 2020, 17(4): 1343-1351., articleTitle=null, refAbstract=null), Reference(id=1329905945326497921, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=ZUO S T, WANG Z Y, AN X Q, et al.Self-assembly engineering nanodrugs composed of paclitaxel and curcumin for the combined treatment of triple negative breast cancer [J].Front Bioeng Biotechnol, 2021, 9: 747637., articleTitle=null, refAbstract=null), Reference(id=1329905945393606786, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=GUO Y, JIANG K, SHEN Z C, et al.A small molecule nanodrug by self-assembly of dual anticancer drugs and photosensitizer for synergistic near-infrared cancer theranostics[J].ACS Appl Mater Interfaces, 2017, 9(50): 43508-43519., articleTitle=null, refAbstract=null), Reference(id=1329905945452327043, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHENG Y F, QIN C, LI F, et al.Self-assembled thioether-bridged paclitaxel-dihydroartemisinin prodrug for amplified antitumor efficacy-based cancer ferroptotic-chemotherapy [J].Biomater Sci, 2023, 11(9): 3321-3334., articleTitle=null, refAbstract=null), Reference(id=1329905945515241604, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU Z J, DU C, ZHANG Q Y, et al.Exquisite vesicular nanomedicine by paclitaxel mediated co-assembly with camptothecin prodrug [J].Angew Chem Int Ed Engl, 2021,60(38): 21033-21039., articleTitle=null, refAbstract=null), Reference(id=1329905945582350469, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG J, LV F M, WANG D L, et al.Synergistic antitumor effects on drug-resistant breast cancer of paclitaxel/lapatinib composite nanocrystals [J].Molecules, 2020, 25(3): 604., articleTitle=null, refAbstract=null), Reference(id=1329905945657847942, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=SELL M, LOPES A R, ESCUDEIRO M, et al.Application of nanoparticles in cancer treatment: a concise review [J].Nanomaterials (Basel), 2023, 13(21): 2887., articleTitle=null, refAbstract=null), Reference(id=1329905945729151111, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=DUAN H X, LIU C, HOU Y, et al.Sequential delivery of quercetin and paclitaxel for the fibrotic tumor microenvironment remodeling and chemotherapy potentiation via a dual-targeting hybrid micelle-in-liposome system [J].ACS Appl Mater Interfaces, 2022, 14(8): 10102-10116., articleTitle=null, refAbstract=null), Reference(id=1329905945804648584, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=LI J, WANG F, SUN D, et al.A review of the ligands and related targeting strategies for active targeting of paclitaxel to tumours [J].J Drug Target, 2016, 24(7): 590-602., articleTitle=null, refAbstract=null), Reference(id=1329905945867563145, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=WEI Y M, ZENG M T, PI C, et al.Novel curcumin derivative-decorated ultralong-circulating paclitaxel nanoparticles: a novel delivery system with superior anticancer efficacy and safety [J].Int J Nanomedicine, 2022, 17: 5265-5286., articleTitle=null, refAbstract=null), Reference(id=1329905945934672010, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=YANG L P, HE J, TAO Z C, et al.GSH-responsive poly-resveratrol based nanoparticles for effective drug delivery and reversing multidrug resistance [J].Drug Deliv, 2022, 29(1): 229-237., articleTitle=null, refAbstract=null), Reference(id=1329905945993392267, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=QU H J, YANG J F, LI S J, et al.Programmed-response cross-linked nanocarrier for multidrug-resistant ovarian cancer treatment [J].J Control Release, 2023, 357: 274-286., articleTitle=null, refAbstract=null), Reference(id=1329905946060501132, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU L Z, WU J, SUN Z, et al.Oxidation and reduction dual-responsive polymeric prodrug micelles co-delivery precisely prescribed paclitaxel and honokiol for laryngeal carcinoma combination therapy [J].Front Pharmacol, 2022,13: 934632., articleTitle=null, refAbstract=null), Reference(id=1329905946140192909, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=YOU X Y, LIU H, CHEN Y, et al.Multifunctional liposomes co-modified with ginsenoside compound K and hyaluronic acid for tumor-targeted therapy [J].Polymers (Basel), 2024,16(3): 405., articleTitle=null, refAbstract=null), Reference(id=1329905946207301774, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=LUO K P, YANG L, YAN C M, et al.A dual-targeting liposome enhances triple-negative breast cancer chemoimmunotherapy through inducing immunogenic cell death and inhibiting STAT3 activation [J].Small, 2023,19(40): e2302834., articleTitle=null, refAbstract=null), Reference(id=1329905946270216335, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG S W, JIANG H, WANG J, et al.Superior in vitro anticancer effect of biomimetic paclitaxel and triptolide co-delivery system in gastric cancer [J].J Biomed Res, 2021,35(4): 327-338., articleTitle=null, refAbstract=null), Reference(id=1329905946337325200, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG K Y, YE H, ZHANG X B, et al.An exosome-like programmable-bioactivating paclitaxel prodrug nanoplatform for enhanced breast cancer metastasis inhibition [J].Biomaterials, 2020, 257: 120224., articleTitle=null, refAbstract=null), Reference(id=1329905946425405585, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=KHAN H, MIRZAEI H R, AMIRI A, et al.Glyco-nanoparticles: new drug delivery systems in cancer therapy[J].Semin Cancer Biol, 2021, 69: 24-42., articleTitle=null, refAbstract=null), Reference(id=1329905946488320146, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=SINGH S, PAL K.Polyphenol modified CuO nanorods capped by kappa-carrageenan for controlled paclitaxel release in furnishing targeted chemotherapy in breast carcinoma cells[J].Int J Biol Macromol, 2024, 255: 127893., articleTitle=null, refAbstract=null), Reference(id=1329905946551234707, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU W, HAN Y, XIN X, et al.Correction: biomimetic and temporal-controlled nanocarriers with ileum transporter targeting for achieving oral administration of chemotherapeutic drugs [J].J Nanobiotechnology, 2022, 20(1): 541., articleTitle=null, refAbstract=null), Reference(id=1329905946614149268, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=XIANG J, ZHAO R, WANG B, et al.Advanced nano-carriers for anti-tumor drug loading [J].Front Oncol, 2021,11: 758143., articleTitle=null, refAbstract=null), Reference(id=1329905946689646741, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG M M, YING N, CHEN J, et al.Engineering a pH-responsive polymeric micelle co-loaded with paclitaxel and triptolide for breast cancer therapy [J].Cell Prolif, 2024,57(6): e13603., articleTitle=null, refAbstract=null), Reference(id=1329905946752561302, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=GUO Y F, LIU S, LUO F Z, et al.A nanosized codelivery system based on intracellular stimuli-triggered dual-drug release for multilevel chemotherapy amplification in drug-resistant breast cancer [J].Pharmaceutics, 2022, 14(2): 422., articleTitle=null, refAbstract=null), Reference(id=1329905946832253079, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=ZAMANI P, PENSON P E, BARRETO G E, et al.Recent advancements in liposome-based strategies for effective drug delivery to the brain [J].Curr Med Chem, 2021, 28(21): 4152-4171., articleTitle=null, refAbstract=null), Reference(id=1329905946903556248, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHU Y, WANG A N, ZHANG S Y, et al.Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells [J].J Adv Res, 2023, 49: 159-173., articleTitle=null, refAbstract=null), Reference(id=1329905946970665113, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG L, KONG L, HE S Y, et al.The anti-ovarian cancer effect of RPV modified paclitaxel plus schisandra B liposomes in SK-OV-3 cells and tumor-bearing mice [J].Life Sci, 2021,285: 120013., articleTitle=null, refAbstract=null), Reference(id=1329905947046162586, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=SHAH S, RANGARAJ N, LAXMIKESHAV K, et al.Nanogels as drug carriers - introduction, chemical aspects,release mechanisms and potential applications [J].Int J Pharm, 2020, 581: 119268., articleTitle=null, refAbstract=null), Reference(id=1329905947121660059, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU Z Q, RAMAKRISHNA S, LIU X L.Electrospinning and emerging healthcare and medicine possibilities [J].APL Bioeng, 2020, 4(3): 030901., articleTitle=null, refAbstract=null), Reference(id=1329905947197157532, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=NGUYEN D T, NGUYEN T P, DINH V T, et al.Potential from synergistic effect of quercetin and paclitaxel co-encapsulated in the targeted folic-gelatin-pluronic P123 nanogels for chemotherapy [J].Int J Biol Macromol, 2023,243: 125248., articleTitle=null, refAbstract=null), Reference(id=1329905947268460701, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=IRANI M, NODEH S M.PVA/κ-carrageenan/Au/camptothecin/pegylated-polyurethane/paclitaxel nanofibers against lung cancer treatment [J].RSC Adv, 2022, 12(25): 16310-16318., articleTitle=null, refAbstract=null), Reference(id=1329905947335569566, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=SOPRANO E, POLO E, PELAZ B, et al.Biomimetic cell-derived nanocarriers in cancer research [J].J Nanobiotechnology, 2022, 20(1): 538., articleTitle=null, refAbstract=null), Reference(id=1329905947423649951, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=QIN M, DU G S, SUN X.Biomimetic cell-derived nanocarriers for modulating immune responses [J].Biomater Sci, 2020, 8(2): 530-543., articleTitle=null, refAbstract=null), Reference(id=1329905947490758816, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=LI M F, LIU Y F, LIU F, et al.Extracellular vesicle-based antitumor nanomedicines [J].Adv Healthc Mater, 2025,14(9): e2403903., articleTitle=null, refAbstract=null), Reference(id=1329905947574644897, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=MENDANHA D, VIEIRA DE CASTRO J, FERREIRA H, et al.Biomimetic and cell-based nanocarriers - new strategies for brain tumor targeting [J].J Control Release, 2021, 337: 482-493., articleTitle=null, refAbstract=null), Reference(id=1329905947662725282, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=WIKLANDER O P B, NORDIN J Z, O’LOUGHLIN A, et al.Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting [J].J Extracell Vesicles, 2015, 4: 26316., articleTitle=null, refAbstract=null), Reference(id=1329905947734028451, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=YIN M H, SUN H R, LI Y N, et al.Delivery of mRNA using biomimetic vectors: progress and challenges [J].Small,2024, 20(43): 2402715., articleTitle=null, refAbstract=null), Reference(id=1329905947796943012, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=HE Y F, WANG X L, DENG S P, et al.Latest progress in low-intensity pulsed ultrasound for studying exosomes derived from stem/progenitor cells [J].Front Endocrinol (Lausanne),2023, 14: 1286900., articleTitle=null, refAbstract=null), Reference(id=1329905947868246181, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=CAO J X, XU Y Y, ZHANG J, et al.“Nano-in-Micro”structured dry powder inhalers for pulmonary delivery: advances and challenges [J].J Drug Deliv Sci Technol, 2024,96: 105648., articleTitle=null, refAbstract=null), Reference(id=1329905947947937958, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=LEE W H, LOO C Y, TRAINI D, et al.Development and evaluation of paclitaxel and curcumin dry powder for inhalation lung cancer treatment [J].Pharmaceutics, 2020,13(1): 9., articleTitle=null, refAbstract=null), Reference(id=1329905948023435431, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=KANG H Z, ZUO Z, LIN R, et al.The most promising microneedle device: present and future of hyaluronic acid microneedle patch [J].Drug Deliv, 2022, 29(1): 3087-3110., articleTitle=null, refAbstract=null), Reference(id=1329905948094738600, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[55], rfOrder=54, authorNames=null, journalName=null, refType=null, unstructuredReference=李昊城.人参多糖修饰的载纳米结晶微针用于提高多西紫杉醇透皮吸收的研究[D].南昌: 江西中医药大学硕士学位论文, 2023., articleTitle=null, refAbstract=null)], funds=[Fund(id=1329905944072401009, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, awardId=23ZR1463700, language=CN, fundingSource=上海市自然科学基金项目(23ZR1463700), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1329905942654726232, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, xref=null, ext=[AuthorCompanyExt(id=1329905942663114841, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, companyId=1329905942654726232, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai 201203), AuthorCompanyExt(id=1329905942675697754, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, companyId=1329905942654726232, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海中医药大学公共健康学院,上海 201203)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2025.10.002, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2025.10.002, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2025.10.002, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2025.10.002, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1760025600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
紫杉醇与天然产物共递送系统抗肿瘤应用的研究进展
张义宏 , 谢燕 *
中国医药工业杂志 | 专论与综述 2025,56(10): 1252-1260
收起
收藏切换
中国医药工业杂志 |专论与综述 2025 , 56 (10) : 1252 -1260
紫杉醇与天然产物共递送系统抗肿瘤应用的研究进展
全屏
[Author(id=1329905942726029404, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905942847664222, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, authorId=1329905942726029404, language=EN, stringName=Yihong ZHANG, firstName=Yihong, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=School of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905942918967391, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, authorId=1329905942726029404, language=CN, stringName=张义宏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海中医药大学公共健康学院,上海 201203, bio={"content":"

张义宏,硕士研究生,专业方向:中药制剂新技术的研究与应用。

"}, bioImg=null, bioContent=

张义宏,硕士研究生,专业方向:中药制剂新技术的研究与应用。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905942654726232, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, xref=null, ext=[AuthorCompanyExt(id=1329905942663114841, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, companyId=1329905942654726232, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai 201203), AuthorCompanyExt(id=1329905942675697754, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, companyId=1329905942654726232, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海中医药大学公共健康学院,上海 201203)])]), Author(id=1329905942986076257, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329905943082545251, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, authorId=1329905942986076257, language=EN, stringName=Yan XIE, firstName=Yan, middleName=null, lastName=XIE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=School of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905943149654116, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, authorId=1329905942986076257, language=CN, stringName=谢燕, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=上海中医药大学公共健康学院,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905942654726232, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, xref=null, ext=[AuthorCompanyExt(id=1329905942663114841, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, companyId=1329905942654726232, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai 201203), AuthorCompanyExt(id=1329905942675697754, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905941912334421, companyId=1329905942654726232, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海中医药大学公共健康学院,上海 201203)])])]
张义宏, 谢燕*
作者信息
  • 上海中医药大学公共健康学院,上海 201203
通讯作者:
谢燕,研究员,博士生导师,从事中药制剂新技术的研究与应用。
作者简介:

张义宏,硕士研究生,专业方向:中药制剂新技术的研究与应用。

Research Progress of Co-delivery Systems Containing Paclitaxel and Traditional Chinese Medicine Components for Antitumor Applications
Yihong ZHANG, Yan XIE*
Affiliations
  • School of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai 201203
出版时间: 2025-10-10 doi: 10.16522/j.cnki.cjph.2025.10.002
文章导航
收藏切换

许多天然产物被证实能增强紫杉醇的抗肿瘤活性并降低其不良反应。然而,紫杉醇与天然产物的共递送仍是药剂学领域的重大挑战。近年来,通过药物自组装、药物载体、新型制剂形式等策略,已实现将天然产物与紫杉醇同时递送至肿瘤部位。这些策略能实现天然产物和紫杉醇协同作用,从而提高紫杉醇的抗肿瘤活性并克服耐药性。文章对相关文献进行了系统梳理,重点围绕共递送系统的设计思路、释药特征、作用效果阐述该领域的研究进展,以期为共递送紫杉醇与天然产物的抗肿瘤治疗提供研究思路与参考。

紫杉醇  /  天然产物  /  自组装  /  纳米载体  /  仿生纳米载体  /  研究进展

Various nature products have been verified to enhance the antitumor efficacy of paclitaxel and mitigate its toxic and adverse reactions. However, the co-delivery of paclitaxel and natural products remains a significant challenge in the pharmaceutical field. In recent years, strategies such as drug self-assembly, drug carriers, and new formulation forms have been employed to concurrently deliver natural products and paclitaxel to tumor sites, aiming to exert their synergistic effects, thereby elevating antitumor activity of paclitaxel and circumventing drug resistance. This article systematically reviews relevant literature, focusing on the design strategies, release characteristics, and therapeutic effects of co-delivery systems, with the aim of providing insights and references for antitumor research combining paclitaxel and natural products.

paclitaxel  /  natural product  /  self-assembly  /  nanocarrier  /  biomimetic nanocarrier  /  research progress
张义宏, 谢燕. 紫杉醇与天然产物共递送系统抗肿瘤应用的研究进展. 中国医药工业杂志, 2025 , 56 (10) : 1252 -1260 . DOI: 10.16522/j.cnki.cjph.2025.10.002
Yihong ZHANG, Yan XIE. Research Progress of Co-delivery Systems Containing Paclitaxel and Traditional Chinese Medicine Components for Antitumor Applications[J]. Chinese Journal of Pharmaceuticals, 2025 , 56 (10) : 1252 -1260 . DOI: 10.16522/j.cnki.cjph.2025.10.002
  • 上海市自然科学基金项目(23ZR1463700)
参考文献 引证文献
排序方式:
[1]
GALLEGO-JARA J, LOZANO-TEROL G, SOLA-MARTÍNEZ R A, et al.A compressive review about taxol®: history and future challenges [J].Molecules, 2020, 25(24): 5986.
[2]
ZHANG S N, YE T Q, LIU Y B, et al.Research advances in clinical applications, anticancer mechanism, total chemical synthesis, semi-synthesis and biosynthesis of paclitaxel [J].Molecules, 2023, 28(22): 7517.
[3]
石英香, 王 婧, 石玉荣, 等.乳腺癌紫杉醇耐药机制的研究进展[J].齐齐哈尔医学院学报, 2022, 43(6): 557-561.
[4]
陆 璐, 郭青龙, 赵 丽.Src激酶家族与紫杉醇耐药相关性的研究进展[J].中国药科大学学报, 2017, 48(4): 377-383.
[5]
NAGANUMA M, TAHARA K, HASEGAWA S, et al.Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the food and drug administration adverse event reporting system [J].SAGE Open Med, 2019, 7: 2050312119836011.
[6]
孔欠文, 陈君君, 胡玉洁, 等.中药单体逆转紫杉醇耐药作用机制的研究进展[J].中国实验方剂学杂志, 2022,28(17): 209-216.
[7]
戴 曦, 唐大春, 袁 竞, 等.和厚朴酚逆转非小细胞肺癌紫杉醇耐药的作用及机制[J].西南医科大学学报, 2024,47(4): 316-320.
[8]
KARAOSMANOGLU S, ZHANG Y, ZHOU W, et al.Synthesis of carrier-free paclitaxel-curcumin nanoparticles: the role of curcuminoids [J].Bioengineering (Basel), 2022,9(12): 815.
[9]
CAI Y, XU Z M, SHUAI Q, et al.Tumor-targeting peptide functionalized PEG-PLA micelles for efficient drug delivery[J].Biomater Sci, 2020, 8(8): 2274-2282.
[10]
CHAN H W, ZHANG X, CHOW S, et al.Inhalable paclitaxel nanoagglomerate dry powders for lung cancer chemotherapy: design of experiments-guided development, characterization and in vitro evaluation [J].Int J Pharm, 2024, 653: 123877.
[11]
KONG Y F, PAN T S, LIU B, et al.Double-layer microneedle patch loaded with HA-PBA-QCT for management of paclitaxel-induced peripheral neuropathic pain [J].Small,2025, 21(8): e2409748.
[12]
QIAO L, YANG H S, GAO S J, et al.Research progress on self-assembled nanodrug delivery systems [J].J Mater Chem B, 2022, 10(12): 1908-1922.
[13]
CHOWDHURY P, NAGESH P K B, HATAMI E, et al.Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells [J].J Colloid Interface Sci, 2019, 535: 133-148.
[14]
程建军, 杨 鑫.三萜天然小分子自组装机制及其协同抗癌应用研究[J].药学学报, 2021, 56(8): 2102-2111.
[15]
BAO Y M, ZHANG S Q, CHEN Z M, et al.Synergistic chemotherapy for breast cancer and breast cancer brain metastases via paclitaxel-loaded oleanolic acid nanoparticles[J].Mol Pharm, 2020, 17(4): 1343-1351.
[16]
ZUO S T, WANG Z Y, AN X Q, et al.Self-assembly engineering nanodrugs composed of paclitaxel and curcumin for the combined treatment of triple negative breast cancer [J].Front Bioeng Biotechnol, 2021, 9: 747637.
[17]
GUO Y, JIANG K, SHEN Z C, et al.A small molecule nanodrug by self-assembly of dual anticancer drugs and photosensitizer for synergistic near-infrared cancer theranostics[J].ACS Appl Mater Interfaces, 2017, 9(50): 43508-43519.
[18]
ZHENG Y F, QIN C, LI F, et al.Self-assembled thioether-bridged paclitaxel-dihydroartemisinin prodrug for amplified antitumor efficacy-based cancer ferroptotic-chemotherapy [J].Biomater Sci, 2023, 11(9): 3321-3334.
[19]
ZHOU Z J, DU C, ZHANG Q Y, et al.Exquisite vesicular nanomedicine by paclitaxel mediated co-assembly with camptothecin prodrug [J].Angew Chem Int Ed Engl, 2021,60(38): 21033-21039.
[20]
WANG J, LV F M, WANG D L, et al.Synergistic antitumor effects on drug-resistant breast cancer of paclitaxel/lapatinib composite nanocrystals [J].Molecules, 2020, 25(3): 604.
[21]
SELL M, LOPES A R, ESCUDEIRO M, et al.Application of nanoparticles in cancer treatment: a concise review [J].Nanomaterials (Basel), 2023, 13(21): 2887.
[22]
DUAN H X, LIU C, HOU Y, et al.Sequential delivery of quercetin and paclitaxel for the fibrotic tumor microenvironment remodeling and chemotherapy potentiation via a dual-targeting hybrid micelle-in-liposome system [J].ACS Appl Mater Interfaces, 2022, 14(8): 10102-10116.
[23]
LI J, WANG F, SUN D, et al.A review of the ligands and related targeting strategies for active targeting of paclitaxel to tumours [J].J Drug Target, 2016, 24(7): 590-602.
[24]
WEI Y M, ZENG M T, PI C, et al.Novel curcumin derivative-decorated ultralong-circulating paclitaxel nanoparticles: a novel delivery system with superior anticancer efficacy and safety [J].Int J Nanomedicine, 2022, 17: 5265-5286.
[25]
YANG L P, HE J, TAO Z C, et al.GSH-responsive poly-resveratrol based nanoparticles for effective drug delivery and reversing multidrug resistance [J].Drug Deliv, 2022, 29(1): 229-237.
[26]
QU H J, YANG J F, LI S J, et al.Programmed-response cross-linked nanocarrier for multidrug-resistant ovarian cancer treatment [J].J Control Release, 2023, 357: 274-286.
[27]
ZHOU L Z, WU J, SUN Z, et al.Oxidation and reduction dual-responsive polymeric prodrug micelles co-delivery precisely prescribed paclitaxel and honokiol for laryngeal carcinoma combination therapy [J].Front Pharmacol, 2022,13: 934632.
[28]
YOU X Y, LIU H, CHEN Y, et al.Multifunctional liposomes co-modified with ginsenoside compound K and hyaluronic acid for tumor-targeted therapy [J].Polymers (Basel), 2024,16(3): 405.
[29]
LUO K P, YANG L, YAN C M, et al.A dual-targeting liposome enhances triple-negative breast cancer chemoimmunotherapy through inducing immunogenic cell death and inhibiting STAT3 activation [J].Small, 2023,19(40): e2302834.
[30]
WANG S W, JIANG H, WANG J, et al.Superior in vitro anticancer effect of biomimetic paclitaxel and triptolide co-delivery system in gastric cancer [J].J Biomed Res, 2021,35(4): 327-338.
[31]
WANG K Y, YE H, ZHANG X B, et al.An exosome-like programmable-bioactivating paclitaxel prodrug nanoplatform for enhanced breast cancer metastasis inhibition [J].Biomaterials, 2020, 257: 120224.
[32]
KHAN H, MIRZAEI H R, AMIRI A, et al.Glyco-nanoparticles: new drug delivery systems in cancer therapy[J].Semin Cancer Biol, 2021, 69: 24-42.
[33]
SINGH S, PAL K.Polyphenol modified CuO nanorods capped by kappa-carrageenan for controlled paclitaxel release in furnishing targeted chemotherapy in breast carcinoma cells[J].Int J Biol Macromol, 2024, 255: 127893.
[34]
LIU W, HAN Y, XIN X, et al.Correction: biomimetic and temporal-controlled nanocarriers with ileum transporter targeting for achieving oral administration of chemotherapeutic drugs [J].J Nanobiotechnology, 2022, 20(1): 541.
[35]
XIANG J, ZHAO R, WANG B, et al.Advanced nano-carriers for anti-tumor drug loading [J].Front Oncol, 2021,11: 758143.
[36]
ZHANG M M, YING N, CHEN J, et al.Engineering a pH-responsive polymeric micelle co-loaded with paclitaxel and triptolide for breast cancer therapy [J].Cell Prolif, 2024,57(6): e13603.
[37]
GUO Y F, LIU S, LUO F Z, et al.A nanosized codelivery system based on intracellular stimuli-triggered dual-drug release for multilevel chemotherapy amplification in drug-resistant breast cancer [J].Pharmaceutics, 2022, 14(2): 422.
[38]
ZAMANI P, PENSON P E, BARRETO G E, et al.Recent advancements in liposome-based strategies for effective drug delivery to the brain [J].Curr Med Chem, 2021, 28(21): 4152-4171.
[39]
ZHU Y, WANG A N, ZHANG S Y, et al.Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells [J].J Adv Res, 2023, 49: 159-173.
[40]
ZHANG L, KONG L, HE S Y, et al.The anti-ovarian cancer effect of RPV modified paclitaxel plus schisandra B liposomes in SK-OV-3 cells and tumor-bearing mice [J].Life Sci, 2021,285: 120013.
[41]
SHAH S, RANGARAJ N, LAXMIKESHAV K, et al.Nanogels as drug carriers - introduction, chemical aspects,release mechanisms and potential applications [J].Int J Pharm, 2020, 581: 119268.
[42]
LIU Z Q, RAMAKRISHNA S, LIU X L.Electrospinning and emerging healthcare and medicine possibilities [J].APL Bioeng, 2020, 4(3): 030901.
[43]
NGUYEN D T, NGUYEN T P, DINH V T, et al.Potential from synergistic effect of quercetin and paclitaxel co-encapsulated in the targeted folic-gelatin-pluronic P123 nanogels for chemotherapy [J].Int J Biol Macromol, 2023,243: 125248.
[44]
IRANI M, NODEH S M.PVA/κ-carrageenan/Au/camptothecin/pegylated-polyurethane/paclitaxel nanofibers against lung cancer treatment [J].RSC Adv, 2022, 12(25): 16310-16318.
[45]
SOPRANO E, POLO E, PELAZ B, et al.Biomimetic cell-derived nanocarriers in cancer research [J].J Nanobiotechnology, 2022, 20(1): 538.
[46]
QIN M, DU G S, SUN X.Biomimetic cell-derived nanocarriers for modulating immune responses [J].Biomater Sci, 2020, 8(2): 530-543.
[47]
LI M F, LIU Y F, LIU F, et al.Extracellular vesicle-based antitumor nanomedicines [J].Adv Healthc Mater, 2025,14(9): e2403903.
[48]
MENDANHA D, VIEIRA DE CASTRO J, FERREIRA H, et al.Biomimetic and cell-based nanocarriers - new strategies for brain tumor targeting [J].J Control Release, 2021, 337: 482-493.
[49]
WIKLANDER O P B, NORDIN J Z, O’LOUGHLIN A, et al.Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting [J].J Extracell Vesicles, 2015, 4: 26316.
[50]
YIN M H, SUN H R, LI Y N, et al.Delivery of mRNA using biomimetic vectors: progress and challenges [J].Small,2024, 20(43): 2402715.
[51]
HE Y F, WANG X L, DENG S P, et al.Latest progress in low-intensity pulsed ultrasound for studying exosomes derived from stem/progenitor cells [J].Front Endocrinol (Lausanne),2023, 14: 1286900.
[52]
CAO J X, XU Y Y, ZHANG J, et al.“Nano-in-Micro”structured dry powder inhalers for pulmonary delivery: advances and challenges [J].J Drug Deliv Sci Technol, 2024,96: 105648.
[53]
LEE W H, LOO C Y, TRAINI D, et al.Development and evaluation of paclitaxel and curcumin dry powder for inhalation lung cancer treatment [J].Pharmaceutics, 2020,13(1): 9.
[54]
KANG H Z, ZUO Z, LIN R, et al.The most promising microneedle device: present and future of hyaluronic acid microneedle patch [J].Drug Deliv, 2022, 29(1): 3087-3110.
[55]
李昊城.人参多糖修饰的载纳米结晶微针用于提高多西紫杉醇透皮吸收的研究[D].南昌: 江西中医药大学硕士学位论文, 2023.
2025年第56卷第10期
27
7
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2025.10.002
  • 接收时间:2025-07-21
  • 首发时间:2026-11-18
  • 出版时间:2025-10-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-07-21
基金
上海市自然科学基金项目(23ZR1463700)
作者信息
    上海中医药大学公共健康学院,上海 201203

通讯作者:

谢燕,研究员,博士生导师,从事中药制剂新技术的研究与应用。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2025.10.002
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏